Rapid identification of pathogens in food and water holds the power to save lives. Katherine Clayton, Founder and CEO of OmniVis, has developed a technology that puts the power of a pathogen lab in hands around the world. She joins us to talk about her personal story paving the way for this innovation, her passion for proactively stopping disease from happening and moving from California to study at Purdue University. So what does a handheld lab entail? Katherine talks about her device, iSpyDx, and its ability to quickly turn results (40 minutes), a focus on ease of use (it weighs under 2 pounds) and COVID-19 rapid tests as market validation for the work the OmniVis team was doing at the time. She also examines this innovation as a tool for crowdsourcing insights on infectious diseases and what’s ahead for the company. Learn more at omnivistech.com.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Erich G. Anderer, Chief of the Division of Neurosurgery and Surgical Director of Perioperative Services at NYU Langone Hospital–Brooklyn
09 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Nolan Wessell, Assistant Professor and Well-being Co-Director, Department of Orthopedic Surgery, Division of Spine Surgery, University of Colorado School of Medicine
08 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-08-2025 1AM EST
08 Dec 2025
NPR News Now